| Authors: |
Hu YF; PhD Program for Health Science and Industry, China Medical University, Taichung, Taiwan., Chen AY; Department of Pathology, Stanford University, Stanford, CA, USA; Department of Bioengineering, Stanford University, CA, USA., Chang JW; PhD Program for Health Science and Industry, China Medical University, Taichung, Taiwan., Chen SY; Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland., Li IC; Biotech Research Institute, Grape King Bio Ltd., Taoyuan, Taiwan., Chou RH; The Ph.D. Program of Biotechnology and Biomedical Industry, and Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan; Center for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan; Department of Medical Laboratory and Biotechnology, Asia University, Taichung, Taiwan., Lin TW; Biotech Research Institute, Grape King Bio Ltd., Taoyuan, Taiwan., Wu SP; CancerFree Biotech Ltd., Taipei, Taiwan., Lu LS; TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan; Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan; International Ph. D. Program for Cell Therapy and Regenerative Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Department of Radiation Oncology, Taipei Medical University Hospital, Taipei, Taiwan. Electronic address: lslu@tmu.edu.tw., Li TJ; Biotech Research Institute, Grape King Bio Ltd., Taoyuan, Taiwan. Electronic address: tsungju.li@grapeking.com.tw., Chen CC; Biotech Research Institute, Grape King Bio Ltd., Long Tan Dist., Taoyuan City 325, Taiwan; Institute of BioPharmaceutical Science, National Sun Yat-sen University, Kaohsiung 804, Taiwan; Institute of Food Science and Technology, National Taiwan University, Taipei 106, Taiwan. Electronic address: gkbioeng@grapeking.com.tw. |
